0521779407-14 CUNY1086/Karliner 0 521 77940 7 June 4, 2007 21:16
1016 Multiple Sclerosis
MULTIPLE SCLEROSIS
MICHAEL J. AMINOFF, MD, DSc
history & physical
■Onset typically btwn 15 & 55 years
■Weakness, sensory disturbances, ataxia, dysarthria, vertigo, sphinc-
ter disturbances, retrobulbar optic neuritis, diplopia occur alone or
in any combination
■Symptoms develop episodically, followed often by partial remission,
leading to progressive disability; sometimes progressive from onset
or after initial relapsing-remitting course
■Variable interval (sometimes of years) btwn episodes; in a few pts,
disorder is progressive from onset
■Relapses may be triggered by infection or in postpartum period
■Findings vary in different pts & at different times in the same pt
■Cognitive deficits, emotional lability, dysarthria are common
■Cranial nerve deficits include optic atrophy, nystagmus, internuclear
ophthalmoplegia, facial sensory loss
■Deficits in limbs include spasticity, pyramidal weakness, ataxia,
intention tremor, sensory loss, hyperreflexia, extensor plantar
responses
tests
■Cranial & spinal MRI reveals multiple white-matter lesions
■Cerebral evoked potentials may reveal subclinical involvement of
afferent pathways
■CSF may show mild pleocytosis, elevated IgG, oligoclonal bands
differential diagnosis
■Depends on symptoms & signs; should be evidence of multiple
lesions affecting CNS white matter & developing at different times
■If deficit can be attributed by lesion at a single site, a structural lesion
must be excluded by imaging
management
■Acute optic neuritis treated w/ IV methylprednisolone
■Acute relapses require steroids (eg, prednisone daily for 1 week, fol-
lowed by taper)